Literature DB >> 11170863

New aspects of integrin signaling in cancer.

L V Parise1, J Lee, R L Juliano.   

Abstract

Members of the integrin family of cell adhesion receptors influence several important aspects of cancer cell behavior, including motility and invasiveness, cell growth, and cell survival. Engagement of integrins with extracellular matrix (ECM) proteins can activate members of the Rho-family of small GTPases; conversely, Rho- and Ras-family proteins can influence the ability of integrins to bind their ligands. These events impinge on the control of cell motility, and ultimately on invasive and metastatic behavior. Integrin engagement with ECM also has important effects on cell survival, particularly for cells of epithelial origin. In some cases, specific integrins have selective effects on the efficiency of signal transduction in cell survival pathways. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11170863     DOI: 10.1006/scbi.2000.0337

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  37 in total

1.  Targeted therapies for killing tumor cells.

Authors:  A F Gazdar; J D Minna
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

2.  Inhibition of Rac GTPase triggers a c-Jun- and Bim-dependent mitochondrial apoptotic cascade in cerebellar granule neurons.

Authors:  Shoshona S Le; F Alexandra Loucks; Hiroshi Udo; Sarah Richardson-Burns; Reid A Phelps; Ron J Bouchard; Holger Barth; Klaus Aktories; Kenneth L Tyler; Eric R Kandel; Kim A Heidenreich; Daniel A Linseman
Journal:  J Neurochem       Date:  2005-08       Impact factor: 5.372

Review 3.  Integrins in prostate cancer progression.

Authors:  Hira Lal Goel; Jing Li; Sophia Kogan; Lucia R Languino
Journal:  Endocr Relat Cancer       Date:  2008-06-04       Impact factor: 5.678

4.  Integrin dependence of Calu-1 cell motility on endothelial extracellular matrix proteins.

Authors:  Adele Wright; Yu-Hua Li; Cheng Zhu
Journal:  Ann Biomed Eng       Date:  2008-04-09       Impact factor: 3.934

5.  Association between ITGA2 C807T polymorphism and gastric cancer risk.

Authors:  Jie Chen; Nan-Nan Liu; Jia-Qi Li; Li Yang; Ying Zeng; Xiao-Mei Zhao; Lin-Lin Xu; Xuan Luo; Bin Wang; Xue-Rong Wang
Journal:  World J Gastroenterol       Date:  2011-06-21       Impact factor: 5.742

6.  Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer.

Authors:  Geertje van der Horst; Christel van den Hoogen; Jeroen T Buijs; Henry Cheung; Henny Bloys; Rob C M Pelger; Giocondo Lorenzon; Bertrand Heckmann; Jean Feyen; Philippe Pujuguet; Roland Blanque; Philippe Clément-Lacroix; Gabri van der Pluijm
Journal:  Neoplasia       Date:  2011-06       Impact factor: 5.715

Review 7.  Phosphoinositides in cell architecture.

Authors:  Annette Shewan; Dennis J Eastburn; Keith Mostov
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-08-01       Impact factor: 10.005

8.  Selective amino acid restriction differentially affects the motility and directionality of DU145 and PC3 prostate cancer cells.

Authors:  Ya-Min Fu; Zu-Xi Yu; Huimin Lin; Xing Fu; Gary G Meadows
Journal:  J Cell Physiol       Date:  2008-10       Impact factor: 6.384

9.  beta1 integrin is necessary for ureteric bud branching morphogenesis and maintenance of collecting duct structural integrity.

Authors:  Xi Zhang; Glenda Mernaugh; Dong-Hua Yang; Leslie Gewin; Manakan B Srichai; Raymond C Harris; Juan M Iturregui; Raoul D Nelson; Donald E Kohan; Dale Abrahamson; Reinhard Fässler; Peter Yurchenco; Ambra Pozzi; Roy Zent
Journal:  Development       Date:  2009-08-26       Impact factor: 6.868

10.  The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy.

Authors:  Xinjie Lu; Dong Lu; Mike Scully; Vijay Kakkar
Journal:  Perspect Medicin Chem       Date:  2008-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.